Pure Extracts Technologies Corp. — Investor Relations & Filings
Filings indexed
99
across all filing types
Latest filing
2023-06-29
Regulatory Filings
Country
CA
Canada
Listing
CSE
PULL
Pure Extracts Technologies Corp. is an integrated plant-based extraction company specializing in the processing of cannabis, hemp, and functional mushrooms. The firm focuses on the development and commercialization of functional and medicinal derivatives, including oils and various derivative products. Leveraging extensive extraction and production experience, the company is also active in the rapidly emerging psychedelic sector, specifically through joint ventures for the extraction and formulation of psilocybin. The company operates an EU-GMP compliant facility, ensuring high standards for its specialized plant-based extracts.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Letter from successor auditor.pdf | 2023-06-29 | English | |
| Notice.pdf | 2023-06-29 | English | |
| Letter from former auditor.pdf | 2023-05-29 | English | |
| Notice.pdf | 2023-05-29 | English | |
| 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2023-02-28 | English | |
| 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2023-02-28 | English |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
8 filings
| |||||
| 28795376 | Letter from successor auditor.pdf | 2023-06-29 | English | ||
| 28795357 | Notice.pdf | 2023-06-29 | English | ||
| 28522357 | Letter from former auditor.pdf | 2023-05-29 | English | ||
| 28522343 | Notice.pdf | 2023-05-29 | English | ||
| 13648134 | 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2023-02-28 | English | ||
| 13648133 | 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2023-02-28 | English | ||
| 13648146 | Interim MD&A - English.pdf | 2023-02-28 | English | ||
| 13648154 | Interim financial statements/report – English.pdf | 2023-02-28 | English | ||
|
2022
7 filings
| |||||
| 25522271 | News release - English.pdf | 2022-08-17 | English | ||
| 25173705 | News release - English.pdf | 2022-07-07 | English | ||
| 25173714 | News release - English.pdf | 2022-07-07 | English | ||
| 25173730 | News release - English.pdf | 2022-07-07 | English | ||
| 13602011 | Material change report - English.pdf | 2022-07-06 | English | ||
| 13601361 | News release - English.pdf | 2022-07-05 | English | ||
| 13572082 | Material change report - English.pdf | 2022-03-15 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
Pure Extracts Technologies Corp. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/45792/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=45792 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=45792 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=45792 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 45792}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Pure Extracts Technologies Corp. (id: 45792)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.